What's happening in Michigan?

[Anonymous]

I am very happy with my rep position at our company and resent the constant stream of malicious misinformation promulgated here by people that have never worked at dendreon. I believe this malicious misinformation is specifically intended to financually hurt me and the company. I am very happy with my position and resent this smear campaign.

I am a robot I am a robot I am a robot, tool, is there any other lies this company can spread??!!

Stay away unless u have no job or you are looking to break into oncology, cause they are running out of friends to hire so now the only ones who come over are those with no experience.

 

[Anonymous]

What you are is an internet troll that has in truth never set foot in a Dendreon facility and fills this board with one fake crisis after the next. Everyone sees that you are just here to post malicious lies about the company so that the hedgefund that employs you can try to profit from any damage you are trying so hard to create with your relentless posting.

 

[Anonymous]

You need a jail cell.

need your daddy?

 

[Anonymous]

Look left and right, but what you see is happening throughout the entire company.

Sales will bump up for a little for a quarter and then keep falling for the next couple of years. That's becoming obvious to us in the field as the central denials are just so darn lame.

 

[Anonymous]

I see the exact opposite in the field. MDs are getting more comfortable with Provenge as a new treatment type with time. I see Provenge sales building momentum with time. Same thing happened to Herceptin, the first monoclonal used to treat breast cancer, where a slow start eventually turned into a blockbuster product:

http://www.gene.com/about-us/investors//historical-product-sales/herceptin

 

[Anonymous]

You need a jail cell.

Steve Thompson paid.

 

[Anonymous]

You got to be kidding right. Provenge is the first immunotherapy ever approved and has only been marketed for 1.5 years since the manufacturing plants were completed in the fall of 2011. A "vaccine" for cancer is a medical breakthrough. It is very very early in the product launch. Combo studies are ongoing with Zytiga, Xtandi, and Vervoy. Any of these studies could show huge synergy between the drugs adding significantly to the combined survival benefit. A low side effect like provenge and whose course of therapy is completed in only 1 month facilities the use of the drug in combo with other drugs. In addition, Dendreon has Neuvenge in phase 2 in bladder cancer which could be another homerun.

I am a Dendreon rep. I think the company is great to work for. The product is true medical innovation. Don't be influenced by internet trolls that have never set foot in a Dendreon facility and fill this board with one fake crisis after the next.

If you are a Dendreon rep then you should know better. The drug's 3 year annniversary of sales is coming up at the end of this month. But don't trust me. Just search for Dendreon's Form 10-K.

"Commercial sale of PROVENGE began in May 2010. Product revenue of $48.0 million in 2010 resulted from commercial sale of PROVENGE following FDA approval on April 29, 2010. Product revenue for 2010 reflects approximately eight months of product sales activity"

"In 2010, we achieved revenue from PROVENGE of $48.0 million. During 2010, we supported commercial sale of PROVENGE from the available capacity at our manufacturing facility in Morris Plains, New Jersey (“New Jersey Facility”). We anticipate our manufacturing capabilities will significantly increase during 2011"

If you look, you'll also find that at the end of 2010 there were 87 employees devoted to sales and marketing. The sad news is that the limited capacity of 12 workstations would conservatively fill only $200,000,000 in sales. As management found out, the real problem wasn't supply but demand.